Valuation: 10x Genomics, Inc.

Market Cap 6.78B 5.87B 5.49B 5.01B 9.45B 647B 9.6B 64.32B 25.24B 323B 25.45B 24.9B 1,077B P/E 2026 *
-72.5x
P/E 2027 * -75.3x
Enterprise Value 6.29B 5.45B 5.09B 4.66B 8.77B 600B 8.91B 59.73B 23.44B 300B 23.64B 23.12B 1,000B EV / Sales 2026 *
10.2x
EV / Sales 2027 * 9.2x
Free-Float
90.53%
Yield 2026 *
-
Yield 2027 * -
1 day+9.71%
1 week+19.32%
Current month+18.67%
1 month+31.27%
3 months+173.63%
6 months+192.92%
Current year+243.92%
1 week 44.39
Extreme 44.39
57.11
1 month 41.6
Extreme 41.6
57.11
Current year 15.9
Extreme 15.9
57.11
1 year 11.16
Extreme 11.16
57.11
3 years 6.78
Extreme 6.78
57.9
5 years 6.78
Extreme 6.78
191.15
10 years 6.78
Extreme 6.78
208.99
Manager TitleAgeSince
Chief Executive Officer 49 2012-07-01
President 51 2012-09-30
Director of Finance/CFO 51 2024-08-11
Director TitleAgeSince
Director/Board Member 51 2012-07-01
Director/Board Member 49 2012-07-01
Chairman 68 2013-07-31
Date Insider Type Main position Quantity % Market Cap.
2/26/26 Free

Founder

88,816 0.0763%
2/26/26 Free

Chief Financial Officer

106,579 0.0915%
2/26/26 Free

Founder

157,895 0.1356%
Change 5-day change 1-year change 3-year change Capi.($)
+9.93%+19.32%+355.68%+8.06% 6.78B
+0.62%+6.40%+208.39%+368.39% 22.61B
+0.62%+1.45%-41.17%-22.92% 9.91B
-0.03%-0.32%+79.90%+48.14% 6.59B
+2.11%+40.62%-24.03% - 6.43B
+1.51%+2.40%-10.99%-11.55% 5.62B
-0.47%+5.58%+82.30%+102.41% 4.51B
+1.17%+1.49%-7.52%-19.60% 4.31B
+1.30%-0.79%-19.78%-35.40% 2.75B
-3.78%+0.09%-55.60%+162.53% 1.46B
Average +1.22%+8.98%+56.72%+66.67% 7.1B
Weighted average by Cap. +1.45%+8.44%+101.84%+138.30%

Financials

2026 *2027 *
Net sales 619M 536M 501M 458M 863M 59.08B 877M 5.88B 2.31B 29.56B 2.33B 2.28B 98.44B 678M 587M 549M 502M 945M 64.7B 960M 6.44B 2.53B 32.37B 2.55B 2.49B 108B
Net income -94.25M -81.6M -76.27M -69.71M -131M -8.99B -133M -894M -351M -4.5B -354M -346M -14.98B -87.84M -76.04M -71.08M -64.96M -122M -8.38B -124M -833M -327M -4.19B -330M -323M -13.96B
Net Debt -484M -419M -392M -358M -675M -46.17B -685M -4.59B -1.8B -23.1B -1.82B -1.78B -76.92B -540M -467M -437M -399M -752M -51.47B -764M -5.12B -2.01B -25.75B -2.03B -1.98B -85.75B
Logo 10x Genomics, Inc.
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
Employees
1,178
Date Price Change Volume
26-08-10 US$56.87 +9.30% 1,875,875
26-08-07 US$52.03 +14.10% 5,434,070
26-08-06 US$45.60 -3.92% 2,515,071
26-08-05 US$47.46 -0.84% 2,498,003
26-08-04 US$47.86 +1.81% 2,655,384
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
52.03USD
Average target price
47.62USD
Spread / Average Target
-8.48%

Quarterly revenue - Rate of surprise